6,6-FUSED HETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS

Title:

6,6-FUSED HETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS

Document Type and Number:

WIPO Patent Application WO/2023/129933

Kind Code:

A3

Abstract:

The present disclosure relates to 6,6-fused heterocyclic compounds and related compounds and their use in treating a disease or condition responsive to modulation or inhibition of METTL3.

Inventors:

CHERUVALLATH ZACHARIA S (US)
VEAL JAMES M (US)
STAFFORD JEFFREY A (US)
MCBRIDE CHRISTOPHER (US)

Application Number:

PCT/US2022/082436

Publication Date:

September 14, 2023

Filing Date:

December 27, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

858 THERAPEUTICS INC (US)

International Classes:

C07D471/06; A61K31/4375; A61P35/02

Domestic Patent References:

WO2006112666A1	2006-10-26
WO2021111124A1	2021-06-10

Attorney, Agent or Firm:

CLARK, David L. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: SYSTEMS AND METHODS IN A DECENTRALIZED NETWORK

Next Patent: SYSTEMS AND METHODS FOR INTEGRATING INTRA-OPERATIVE IMAGE DATA WITH MINIMALLY INVASIVE MEDICAL TECHN...